ED Coding & Reimbursement Alert - 2006 Issue 4
You Be the Coder: What Are the Rules for Neoplasm Dx?
Subscribe or sign in to view the full article.
Article Overview
This coding Q&A discusses ICD-9 neoplasm diagnosis classification for physician settings. It reviews the broad categories used for malignant and benign neoplasms, including primary and secondary malignancy, in situ disease, benign growths, and the distinction between uncertain behavior and unspecified diagnosis. The article is aimed at coders and billing staff who need a high-level understanding of how pathology and surgical documentation affect diagnosis selection.
Why This Topic Matters
Correct neoplasm diagnosis classification affects medical coding accuracy, claim integrity, and consistency with pathology or surgical documentation. Understanding the difference between uncertain and unspecified categories helps avoid misclassification when documentation is limited or when pathology indicates atypia or dysplasia.
Article Sections
-
Question
Introduces the coding question about how neoplasm diagnoses are categorized and how two documentation-related diagnosis categories differ.
-
Answer
Summarizes the major ICD-9 neoplasm groupings and discusses how pathology, origin, and documentation context relate to diagnosis selection.
What You Will Learn
- How ICD-9 groups neoplasms into broad diagnostic categories
- How physician documentation and pathology reports affect neoplasm classification
- How to distinguish general documentation concepts related to uncertain behavior and unspecified diagnosis
- Which types of neoplasm categories are discussed in relation to origin, spread, and behavior
Who Should Read This
- Medical coders
- Billing staff
- Physician practice staff
- Coding educators
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com